Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vision Loss Night”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Large-scale testing (Phase 3)Study completedNCT04638660
What this trial is testing

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

Who this might be right for
Dim Light Vision Disturbances
Ocuphire Pharma, Inc. 144
Testing effectiveness (Phase 2)Study completedNCT01703559
What this trial is testing

The Safety and Efficacy of Phentolamine Mesylate Ophthalmic Solution in Subjects With Severe Night Vision Disturbances

Who this might be right for
Night Vision ComplaintsDecrease in Night VisionDisturbance; Vision, Loss
Ocuphire Pharma, Inc. 60
Not applicableStudy completedNCT02965534
What this trial is testing

Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality

Who this might be right for
Myopia-Night Blindness
University of Applied Sciences Jena 100
Not applicableLooking for participantsNCT06323772
What this trial is testing

Natural History Study in Patients with PDE6A-, PDE6B- and RHO-linked Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
University Hospital Tuebingen 40
Not applicableStudy completedNCT02909985
What this trial is testing

Visual Activity Evoked by Infrared in Humans After Dark Adaptation

Who this might be right for
Age Related Macular DegenerationRetinitis PigmentosaCongenital Stationary Night Blindness+1 more
University of New Mexico 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04123626
What this trial is testing

Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene

Who this might be right for
Autosomal Dominant Retinitis PigmentosaEye DiseasesEye Diseases, Hereditary+5 more
ProQR Therapeutics 11
Not applicableStudy completedNCT06989879
What this trial is testing

Knowledge of Students About Vitamin A and Assessment of Eye Manifestations in Quranic Schools (Khalwai) Khartoum State, Sudan 2022

Who this might be right for
Vitamin A DeficiencyNight Blindness
University of Khartoum 332
Large-scale testing (Phase 3)WithdrawnNCT02053883
What this trial is testing

Cethrin in Acute Cervical Spinal Cord Injury

Who this might be right for
Spinal Cord Injury
BioAxone BioSciences, Inc.
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Not applicableWithdrawnNCT05045703
What this trial is testing

The Dark-Adapted Retinal Function Response in Choroideremia (DARC) Study

Who this might be right for
Choroideremia
Duke University
Not applicableStudy completedNCT04434521
What this trial is testing

Comparison of Different Refraction Measurements in Adults

Who this might be right for
Vision Loss Night
Direction Centrale du Service de Santé des Armées 17
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06349759
What this trial is testing

Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances

Who this might be right for
Mesopic VisionNight Vision Loss
Ocuphire Pharma, Inc. 200
Not applicableStudy completedNCT00569023
What this trial is testing

Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

Who this might be right for
Night Blindness
Sheba Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT00500812
What this trial is testing

A Safety Study for Cethrin (BA-210) in the Treatment of Acute Thoracic and Cervical Spinal Cord Injuries

Who this might be right for
Spinal Cord Injury
Vertex Pharmaceuticals Incorporated 48
Testing effectiveness (Phase 2)Ended earlyNCT05085964
What this trial is testing

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2
Laboratoires Thea 21
Not applicableLooking for participantsNCT06961864
What this trial is testing

Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli

Who this might be right for
Visual Snow SyndromeMigraineHealthy
University of Minnesota 100
Testing effectiveness (Phase 2)Study completedNCT04004507
What this trial is testing

Single Dose Study of Phentolamine Mesylate Eye Drops in Patients With Severe Night Vision Disturbances

Who this might be right for
Decrease in Night VisionDisturbance; Vision, Loss
Ocuphire Pharma, Inc. 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05203939
What this trial is testing

Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis

Who this might be right for
Retinitis PigmentosaLeber Congenital Amaurosis
Ocugen 22
Testing effectiveness (Phase 2)Looking for participantsNCT06921317
What this trial is testing

GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma

Who this might be right for
Primary Open-Angle Glaucoma (POAG)
IVIEW Therapeutics Inc. 12
Load More Results